Natera, Inc. (NTRA) Ownership
NTRA ownership summary
as of October 17, 2026- Institutions
- 96.8% of shares outstanding
- Insiders
- 2.73% of shares outstanding
- Shares outstanding
- 144.1M
- Float
- 140.1M shares available to trade
- Short interest
- 4.54% 6.4M shares short
- Days to cover
- 4.14 short interest up 32.5% vs prior month
- Institutions 96.77%
- Insiders 2.73%
- Other investors 0.50%
NTRA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase & Co | 8.93% | 12.9M | $5.06B | −521,321 (−3.9%) | June 30, 2026 |
| 2 | BlackRock Inc | 7.57% | 10.9M | $4.29B | +237,270 (+2.2%) | June 30, 2026 |
| 3 | T. Rowe Price Associates, Inc. | 6.26% | 9.0M | $3.55B | −3.2M (−26.0%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 4.32% | 6.2M | $2.45B | +219,720 (+3.7%) | June 30, 2026 |
| 5 | Vanguard Portfolio Management, LLC | 4.01% | 5.8M | $2.28B | +137,945 (+2.4%) | June 30, 2026 |
| 6 | FMR Inc | 3.78% | 5.5M | $2.14B | +2.9M (+113.4%) | June 30, 2026 |
| 7 | Wellington Management Company LLP | 2.80% | 4.0M | $1.59B | −727,855 (−15.3%) | June 30, 2026 |
| 8 | State Street Corp | 2.54% | 3.7M | $1.44B | +238,146 (+7.0%) | June 30, 2026 |
| 9 | Duquesne Family Office LLC | 2.21% | 3.2M | $1.25B | +122,700 (+4.0%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 1.91% | 2.8M | $1.08B | −25,915 (−0.9%) | June 30, 2026 |
| 11 | Franklin Templeton Inc | 1.89% | 2.7M | $1.07B | +240,578 (+9.7%) | June 30, 2026 |
| 12 | Castle Hook Partners LP | 1.80% | 2.6M | $1.02B | +66,466 (+2.6%) | June 30, 2026 |
| 13 | Coatue Management LLC | 1.74% | 2.5M | $985.6M | −36,752 (−1.4%) | June 30, 2026 |
| 14 | AQR Capital Management LLC | 1.63% | 2.3M | $922.4M | +70,579 (+3.1%) | June 30, 2026 |
| 15 | Farallon Capital Management, L.L.C. | 1.54% | 2.2M | $872.8M | −989,000 (−30.8%) | June 30, 2026 |
| 16 | Massachusetts Financial Services Company | 1.37% | 2.0M | $775.6M | −68,715 (−3.4%) | June 30, 2026 |
| 17 | NORGES BANK | 1.27% | 1.8M | $719.3M | +202,569 (+12.5%) | June 30, 2026 |
| 18 | Fred Alger Management, LLC | 1.23% | 1.8M | $699.5M | +21,537 (+1.2%) | June 30, 2026 |
| 19 | The Goldman Sachs Group Inc | 1.19% | 1.7M | $676.8M | +952,921 (+124.2%) | June 30, 2026 |
| 20 | Sofinnova Ventures | 1.08% | 1.6M | $609.9M | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 5.4M shares and 7 cut 5.5M.
NTRA top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | JPMorgan Large Cap Growth I | 4.22% | 6.1M | $2.39B | +525,995 (+9.5%) | August 31, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 3.00% | 4.3M | $1.70B | −8,915 (−0.2%) | August 31, 2026 |
| 3 | Vanguard Small Cap Index | 2.17% | 3.1M | $1.23B | +3,619 (+0.1%) | August 31, 2026 |
| 4 | Fidelity Contrafund | 1.41% | 2.0M | $798.1M | +184,829 (+10.0%) | August 31, 2026 |
| 5 | Vanguard MStar Small Cap Growth Indx Inv | 1.25% | 1.8M | $706.9M | −12,314 (−0.7%) | August 31, 2026 |
| 6 | Franklin DynaTech A | 1.04% | 1.5M | $590.2M | +50,000 (+3.4%) | August 31, 2026 |
| 7 | MFS Mid Cap Growth A | 0.93% | 1.3M | $529.4M | — | August 31, 2026 |
| 8 | iShares Biotechnology ETF | 0.73% | 1.1M | $413.2M | −7,960 (−0.8%) | September 30, 2026 |
| 9 | American Funds Growth Fd of Amer A | 0.69% | 989K | $389.0M | — | June 30, 2026 |
| 10 | JPMorgan Mid Cap Growth I | 0.58% | 835K | $328.6M | −15,497 (−1.8%) | August 31, 2026 |
| 11 | T. Rowe Price Mid-Cap Growth | 0.57% | 827K | $325.4M | +146,342 (+21.5%) | August 31, 2026 |
| 12 | Vanguard US Growth Investor | 0.54% | 774K | $304.7M | +180,620 (+30.4%) | June 30, 2026 |
| 13 | iShares Russell Mid-Cap Growth ETF | 0.53% | 768K | $302.3M | −822 (−0.1%) | September 30, 2026 |
| 14 | T. Rowe Price Lrg Cp Gr I | 0.52% | 747K | $293.8M | −16,660 (−2.2%) | August 31, 2026 |
| 15 | T. Rowe Price New Horizons | 0.50% | 715K | $281.1M | −24,719 (−3.3%) | August 31, 2026 |
| 16 | Fidelity Extended Market Index | 0.48% | 698K | $274.5M | −7,162 (−1.0%) | August 31, 2026 |
| 17 | JPMorgan Growth Advantage A | 0.44% | 633K | $249.0M | −9,234 (−1.4%) | August 31, 2026 |
| 18 | Fidelity Select Health Care | 0.40% | 580K | $228.2M | +191,848 (+49.4%) | August 31, 2026 |
| 19 | iShares Russell Mid-Cap ETF | 0.39% | 564K | $221.9M | +1,045 (+0.2%) | September 30, 2026 |
| 20 | Fidelity Mid Cap Index | 0.36% | 519K | $204.4M | +2,061 (+0.4%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NTRA insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | Solomon Moshkevich | Sell | $202.30 | 3,000 | $606,900 |
| 2026-03-13 | Rowan E Chapman | Sell | $191.38 | 122 | $23,348 |
| 2026-03-10 | John Fesko | Sell | $204.13 | 707 | $144,320 |
| 2026-03-10 | Michael Burkes Brophy | Sell | $204.13 | 785 | $160,242 |
| 2026-03-10 | Solomon Moshkevich | Sell | $204.13 | 915 | $186,779 |
| 2026-03-10 | Steven Leonard Chapman | Sell | $204.13 | 5,623 | $1.1M |
| 2026-03-02 | Solomon Moshkevich | Sell | $199.85 | 3,000 | $599,550 |
| 2026-03-02 | Steven Leonard Chapman | Sell | $200.02 | 3,950 | $790,079 |
| 2026-02-03 | Solomon Moshkevich | Sell | $230.77 | 1,639 | $378,232 |
| 2026-02-03 | Steven Leonard Chapman | Sell | $230.77 | 4,725 | $1.1M |
| 2026-02-03 | Michael Burkes Brophy | Sell | $227.83 | 6,939 | $1.6M |
| 2026-02-03 | John Fesko | Sell | $231.02 | 3,594 | $830,286 |
| 2026-02-02 | Solomon Moshkevich | Sell | $231.44 | 3,000 | $694,320 |
| 2026-02-02 | Steven Leonard Chapman | Sell | $230.72 | 85,299 | $19.7M |
| 2026-01-29 | Michael Burkes Brophy | Sell | $230.40 | 1,867 | $430,157 |
| 2026-01-28 | John Fesko | Sell | $237.66 | 928 | $220,548 |
| 2026-01-28 | Michael Burkes Brophy | Sell | $237.56 | 2,413 | $573,232 |
| 2026-01-28 | Solomon Moshkevich | Sell | $237.66 | 1,200 | $285,192 |
| 2026-01-28 | Steven Leonard Chapman | Sell | $237.66 | 3,648 | $866,984 |
| 2026-01-27 | John Fesko | Sell | $240.53 | 784 | $188,576 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
NTRA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NTRA
Institutional investors own 96.8% of Natera's shares and insiders 2.73%. The largest holder is JPMorgan Chase & Co with 8.93% of the shares (12.9M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 7 reduced their stake in the latest filings. Short interest is 4.54% of the float, or 4.14 days of average trading volume. The share count rose 272.7% since 2014.
Related: NTRA analyst forecast, NTRA key metrics. See the NTRA stock overview for the latest quote and news.
NTRA ownership FAQ
Who owns the most Natera stock?
The largest shareholders of Natera are JPMorgan Chase & Co (8.93%), BlackRock Inc (7.57%), T. Rowe Price Associates, Inc. (6.26%), Vanguard Capital Management, LLC (4.32%), Vanguard Portfolio Management, LLC (4.01%).
What percentage of Natera is owned by institutions?
Institutions hold 96.8% of Natera's shares outstanding; insiders hold 2.73%.
Which funds own Natera?
The largest fund holders of Natera are JPMorgan Large Cap Growth I (4.22%), Vanguard MStar Total Stk Mkt Idx Invest (3.00%), Vanguard Small Cap Index (2.17%), Fidelity Contrafund (1.41%), Vanguard MStar Small Cap Growth Indx Inv (1.25%).
What is Natera's short interest?
6.4M shares of Natera were sold short, 4.54% of the float; at the average daily volume it would take 4.14 days to cover.
Are insiders buying or selling Natera?
Of the latest 20 reported insider transactions in Natera (since January 27, 2026), 0 were purchases and 20 were sales.
How many shares of Natera are outstanding?
Natera has 144.1M shares outstanding, of which 140.1M are in the public float.